Understanding pathways to death in patients with COVID-19

Jean Louis Vincent; Fabio Silvio Taccone

doi:10.1016/s2213-2600(20)30165-x

Related publications

Article2021

Late Breaking Abstract - Enhanced immune activation pathways enriched in patients =70 years with severe COVID-19

Luke O'neill, Charlotte Summers, Gift Nyamundanda, Johannes Freudenberg, Anubha Gupta, Julia E. Smith, Sumanta Mukherjee, Jessica Neisen

Article2020

Cardiac arrhythmias in patients with COVID‐19

Yueying Wang, Zhaojia Wang, Gary Tse, Lin Zhang, Elaine Y. Wan, Yutao Guo, Professor Gregory Lip, Guangping Li, Zhibing Lu, Tong Liu

Preprint2020

COVID-19 in Teriflunomide-Treated Patients with Multiple Sclerosis

Amir‐Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara HW Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi

Article2020

COVID-19 in teriflunomide-treated patients with multiple sclerosis

Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi

Letter2021

COVID-19 in patients with cancer: Risks and precautions

AzadehSadat Razavi, Michael R Hamblin, Nima Rezaei